Biovac to start making Pfizer-BioNTech vaccine in early 2022

 

In December SA’s Biovac Institute announced that it will start making Pfizer-BioNTech’s Covid-19 vaccine early next year after receiving the drug substance from facilities in Europe, reported News24 (7 December 2021). The deal to “fill and finish” the vaccine, the final stages of manufacturing where the product is processed and put into vials, will make Biovac one of the few companies processing Covid-19 shots in Africa.

Other news